MyAverix Finance
F · Healthcare
RUBICON ORGANICS INC (R07)
Drug Manufacturers - Specialty & Generic
RUBICON ORGANICS INC (R07) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $19.99M, P/E ratio is 29.00, net margin is 1.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for R07
RUBICON ORGANICS INC (R07) — FAQ
What is RUBICON ORGANICS INC's market cap?
RUBICON ORGANICS INC (R07) has a reported market cap of $19.99M (data as of 2026-03-30).
What is R07's P/E ratio?
The price-to-earnings (P/E) ratio for RUBICON ORGANICS INC (R07) is 29.00 (data as of 2026-03-30).
Does RUBICON ORGANICS INC pay a dividend?
Dividend yield is not available in the current snapshot for RUBICON ORGANICS INC (R07). Check the MyAverix Finance app for the latest dividend data.
What sector is RUBICON ORGANICS INC in?
RUBICON ORGANICS INC (R07) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is R07 listed on?
R07 is listed on F.
What is RUBICON ORGANICS INC's net margin?
RUBICON ORGANICS INC (R07) reports a net margin of 1.8% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.